[
  {
    "ts": null,
    "headline": "Top Stock Reports for Walmart, Toyota Motor & Boston Scientific",
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Toyota Motor Corp. (TM) and Boston Scientific Corp. (BSX), as well as a micro-cap stock Autoscope Technologies Corp. (AATC).",
    "url": "https://finnhub.io/api/news?id=43813b5bc038683b08570253bae4474f6d445244f4a1121f8a32d64b9043c671",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745614380,
      "headline": "Top Stock Reports for Walmart, Toyota Motor & Boston Scientific",
      "id": 134104501,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Toyota Motor Corp. (TM) and Boston Scientific Corp. (BSX), as well as a micro-cap stock Autoscope Technologies Corp. (AATC).",
      "url": "https://finnhub.io/api/news?id=43813b5bc038683b08570253bae4474f6d445244f4a1121f8a32d64b9043c671"
    }
  },
  {
    "ts": null,
    "headline": "Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now",
    "summary": "Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
    "url": "https://finnhub.io/api/news?id=01d31fb7f9c32d5978d9cfb46112c2cd6b7472ebcb75beb4d6dff706ed48f945",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745599505,
      "headline": "Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now",
      "id": 134094792,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
      "url": "https://finnhub.io/api/news?id=01d31fb7f9c32d5978d9cfb46112c2cd6b7472ebcb75beb4d6dff706ed48f945"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know",
    "summary": "Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
    "url": "https://finnhub.io/api/news?id=f044e28f2914c49978160ea004be28fb8e19e4daf5d77e3349a2120a0c9d4c4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745596808,
      "headline": "Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know",
      "id": 134094793,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
      "url": "https://finnhub.io/api/news?id=f044e28f2914c49978160ea004be28fb8e19e4daf5d77e3349a2120a0c9d4c4c"
    }
  },
  {
    "ts": null,
    "headline": "MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up",
    "summary": "Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=18880675799274c1d24bb29a447f09e9e78e905f9c15a831ec338924c6a338d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745596800,
      "headline": "MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up",
      "id": 134094794,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=18880675799274c1d24bb29a447f09e9e78e905f9c15a831ec338924c6a338d2"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Boston Scientific (BSX) is a Strong Momentum Stock",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=10b2de0677806b83b943978c28e3a99ded0afdafa655fcbfcb1761731897725c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745589006,
      "headline": "Here's Why Boston Scientific (BSX) is a Strong Momentum Stock",
      "id": 134087810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=10b2de0677806b83b943978c28e3a99ded0afdafa655fcbfcb1761731897725c"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?",
    "summary": "Here is how Boston Scientific (BSX) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=5937e741691709ce68c030ae6780d42f0f2a076bbc87e6f56a74534fd704c927",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745588410,
      "headline": "Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?",
      "id": 134087813,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Here is how Boston Scientific (BSX) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=5937e741691709ce68c030ae6780d42f0f2a076bbc87e6f56a74534fd704c927"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific reports outcomes from Farapulse and Farapoint trial",
    "summary": "Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.",
    "url": "https://finnhub.io/api/news?id=dfa74ade8a8a91666362afdaf83a41bc1b404df84934a2a1b39d70f62ac93ed6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745578366,
      "headline": "Boston Scientific reports outcomes from Farapulse and Farapoint trial",
      "id": 134087815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.",
      "url": "https://finnhub.io/api/news?id=dfa74ade8a8a91666362afdaf83a41bc1b404df84934a2a1b39d70f62ac93ed6"
    }
  },
  {
    "ts": null,
    "headline": "Anumana Expands AI Platform from Diagnostic Solutions to the Full Continuum of Cardiovascular Care",
    "summary": "CAMBRIDGE - Anumana, a leading AI-driven health technology company, has expanded beyond its diagnostic ECG-AI technology into perioperative and acute cardiac care.The company recently brought on...",
    "url": "https://finnhub.io/api/news?id=255a6e079cd9a6f6cd0bb54268be4c625efb836f6528d6d6e658f745eaaed438",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745575959,
      "headline": "Anumana Expands AI Platform from Diagnostic Solutions to the Full Continuum of Cardiovascular Care",
      "id": 134080349,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "CAMBRIDGE - Anumana, a leading AI-driven health technology company, has expanded beyond its diagnostic ECG-AI technology into perioperative and acute cardiac care.The company recently brought on...",
      "url": "https://finnhub.io/api/news?id=255a6e079cd9a6f6cd0bb54268be4c625efb836f6528d6d6e658f745eaaed438"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company",
    "summary": "Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June 30.",
    "url": "https://finnhub.io/api/news?id=b49252a8f71df661a731db11c115c9525dd6e713f45ba52aa9ae81c67661dad8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745570940,
      "headline": "Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company",
      "id": 134087817,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June 30.",
      "url": "https://finnhub.io/api/news?id=b49252a8f71df661a731db11c115c9525dd6e713f45ba52aa9ae81c67661dad8"
    }
  }
]